Aurobindo Pharma share price
You have to be logged in to add this to Watchlist.Aurobindo Pharma is trading 3.37% upper at Rs 1,296.00 as compared to its last closing price. Aurobindo Pharma has been trading in the price range of 1,311.00 & 1,254.90. Aurobindo Pharma has given 15.74% in this year & 5.59% in the last 5 days.
Aurobindo Pharma has TTM P/E ratio 20.12 as compared to the sector P/E of 30.88.There are 24 analysts who have initiated coverage on Aurobindo Pharma. There are 6 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 908.75 Crores in its last quarter.
Listed peers of Aurobindo Pharma include Aurobindo Pharma (3.37%), Pfizer (0.10%), Astrazeneca Pharma India (-3.21%) etc.
Aurobindo Pharma has a 51.83% promoter holding & 48.17% public holding.The Mutual Fund holding in Aurobindo Pharma was at 5.03% in 31 Mar 2024. The MF holding has decreased from the last quarter. The FII holding in Aurobindo Pharma was at 18.01% in 31 Mar 2024. The FII holding has decreased from the last quarter.
Aurobindo Pharma share price range
|
| ||||
|
| ||||
Aurobindo Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 73,514.79 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Aurobindo Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 25-May-24 | Audited Results |
| 10-Feb-24 | Quarterly Results & Interim Dividend |
| 09-Nov-23 | Quarterly Results & Interim Dividend |
| 12-Aug-23 | Quarterly Results |
| 27-May-23 | Audited Results |
| 09-Feb-23 | Quarterly Results & Interim Dividend |
| 12-Nov-22 | Quarterly Results |
| 11-Aug-22 | Quarterly Results |
| 30-May-22 | Audited Results & 4th Interim Dividend |
| 09-Feb-22 | Quarterly Results & 3rd Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 28-Dec-23 | 24-Nov-23 | POM |
| 25-Aug-23 | 28-Jul-23 | AGM |
| 23-Mar-23 | 17-Feb-23 | POM |
| 02-Aug-22 | 07-Jul-22 | AGM |
| 12-Feb-22 | 12-Jan-22 | POM |
| 26-Aug-21 | 03-Aug-21 | AGM |
| 27-Aug-20 | 03-Aug-20 | AGM |
| 29-Aug-19 | 05-Aug-19 | AGM |
| 21-Mar-19 | 15-Feb-19 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 07-Feb-24 | 20-Feb-24 | 20-Feb-24 | 1.5 |
| 02-Nov-23 | 20-Nov-23 | 20-Nov-23 | 3 |
| 03-Feb-23 | 17-Feb-23 | 17-Feb-23 | 3 |
| 20-May-22 | 07-Jun-22 | 06-Jun-22 | 4.5 |
| 09-Feb-22 | 21-Feb-22 | 18-Feb-22 | 1.5 |
| 08-Nov-21 | 18-Nov-21 | 17-Nov-21 | 1.5 |
| 12-Aug-21 | 30-Aug-21 | 27-Aug-21 | 1.5 |
| 10-Feb-21 | 23-Feb-21 | 22-Feb-21 | 1.5 |
| 11-Nov-20 | 24-Nov-20 | 23-Nov-20 | 1.25 |
| 12-Aug-20 | - | 21-Aug-20 | 1.25 |
FAQs about Aurobindo Pharma share price
Aurobindo Pharma is trading at 1296.00 as on Fri Jul 05 2024 09:59:45. This is 3.37% upper as compared to its previous closing price of 1253.75.
The market capitalization of Aurobindo Pharma is 75932.64 Cr as on Fri Jul 05 2024 09:59:45.
The average broker rating on Aurobindo Pharma is Buy. The breakup of analyst rating is given below -
- 6 analysts have given a strong buy rating
- 12 analysts have given a buy rating
- 3 analysts have given a hold rating
- 1 analysts have given a sell rating
- 2 analysts have given a strong sell rating
The 52 wk high for Aurobindo Pharma is 1292.15 whereas the 52 wk low is 709.00
Aurobindo Pharma can be analyzed on the following key metrics -
- TTM P/E: 20.12
- Sector P/E: 30.88
- Dividend Yield: 0.36%
- D/E ratio: 0.22
Aurobindo Pharma reported a net profit of 3172.97 Cr in 2024.
Aurobindo Pharma Quick Links
Aurobindo Pharma Dividend Aurobindo Pharma Bonus Aurobindo Pharma News Aurobindo Pharma AGM Aurobindo Pharma Rights Aurobindo Pharma Splits Aurobindo Pharma Board Meetings Aurobindo Pharma Key Metrics Aurobindo Pharma Shareholdings Aurobindo Pharma Profit Loss Aurobindo Pharma Balance Sheet Aurobindo Pharma Cashflow Aurobindo Pharma Q1 Results Aurobindo Pharma Q2 Results Aurobindo Pharma Q3 Results Aurobindo Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks